Partex NV and Fortress Biotech (FBIO) announced a strategic collaboration aimed at identifying and evaluating biopharmaceutical compounds using ...
Partex's platform will provide comprehensive analyses, including target identification, indication expansion, and molecular profiling, ultimately accelerating the process of bringing innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results